Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
Condition(s) studied
Investigational drug(s) / intervention(s)
Salovum/SPC flakes: Egg yolk powder and specially processed cereals
Study summary
The objective of this clinical trial is to explore the effects of Salovum®, an egg yolk powder enriched with the endogenous protein antisecretory factor, and SPC® flakes , hydrothermically processed oats, on cerebral edema with clinical symptoms in participants with brain tumors.
The primary questions the trial seeks to answer are:
* Can Salovum® and SPC® flakes have effect on clinical symptoms of tumor-induced cerebral edema?
* Can Salovum® and SPC® flakes induce regression of radiological edema in tumor-induced cerebral edema Additionally, the study will investigate the impact of Salovum® and SPC® flakes in steroid refractory, steroid naïve cerebral edema and type of barin tumor
Researchers will:
Evaluate edema change from baseline by MRI after 14 days Evaluate neurological and cognitive symptoms Register dose of steroid medications
Participants will:
* Ingest Salovum® 11g three times daily for 14 days, thereafter tapered during 14 days
* Ingest SPC® flakes 1g/kg daily from day 7
Eligibility
Primary outcome measure(s)
- Change of neurological symptoms — 28 days
To investigate whether Salovum® and SPC® flakes can change neurological symptoms in participants with tumor induced cerebral oedema as measured by the neurologic assessment in neurooncology (NANO) scale (range 0-23, 0 best-23 worst)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Neurosurgery | Lund | Sweden | Recruiting |
More Peter Siesjö trials in Sweden
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06710249 on ClinicalTrials.gov ↗ ← All trials in Sweden